相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic
Janet M. Sasso et al.
BIOCHEMISTRY (2023)
Development of a versatile nuclease prime editor with upgraded precision
Xiangyang Li et al.
NATURE COMMUNICATIONS (2023)
Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein
Hong-Beom Park et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Over-expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells
Weiwei Chen et al.
CANCER GENETICS (2023)
TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation
Feier Zeng et al.
SCIENTIFIC REPORTS (2023)
USP15 Represses Hepatocellular Carcinoma Progression by Regulation of Pathways of Cell Proliferation and Cell Migration: A System Biology Analysis
Yiyue Ren et al.
CANCERS (2023)
TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation
Feier Zeng et al.
SCIENTIFIC REPORTS (2023)
The E2 ubiquitin-conjugating enzyme HIP2 is a crucial regulator of quality control against mutant SOD1 proteotoxicity
Yeong Jin Tak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3
Chad S. Hewitt et al.
BIOMOLECULES (2022)
Panel of Engineered Ubiquitin Variants Targeting the Family ofHuman Ubiquitin Interacting Motifs
Gianluca Veggiani et al.
ACS CHEMICAL BIOLOGY (2022)
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction
Mi-Jeong Kim et al.
CELL DEATH & DISEASE (2022)
Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
Bayonle Aminu et al.
BIOMOLECULES (2022)
A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells
Wynton D. McClary et al.
ACS CHEMICAL BIOLOGY (2022)
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site
Vera J. E. van Vliet et al.
PLOS PATHOGENS (2022)
Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease
Xin Pan et al.
BIOMOLECULES (2022)
Targeted protein degradation: mechanisms, strategies and application
Lin Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Therapeutic peptides: current applications and future directions
Lei Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
Yusong Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Structure-Activity Relationship of USP5 Inhibitors
Mandeep K. Mann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Panel of Engineered Ubiquitin Variants Targeting the Family of Domains Found in Ubiquitin Specific Proteases (DUSPs)
Jason Q. Tang et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function
Frances M. Potjewyd et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Identification of Ubiquitin Variants That Inhibit the E2 Ubiquitin Conjugating Enzyme, Ube2k
Adam J. Middleton et al.
ACS CHEMICAL BIOLOGY (2021)
Engineering Single Pan-Specific Ubiquibodies for Targeted Degradation of All Forms of Endogenous ERK Protein Kinase
Erin A. Stephens et al.
ACS SYNTHETIC BIOLOGY (2021)
E3 ubiquitin ligases: styles, structures and functions
Quan Yang et al.
MOLECULAR BIOMEDICINE (2021)
An E3 ligase guide to the galaxy of small-molecule-induced protein degradation
Predrag Jevtic et al.
CELL CHEMICAL BIOLOGY (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Proteasome Inhibitor Drugs
Lloyd D. Fricker
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Structural and Functional Analysis of Ubiquitin-based Inhibitors That Target the Backsides of E2 Enzymes
Pankaj Garg et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
NEDD4 E3 ligase: Functions and mechanism in human cancer
Zhi-Wei Wang et al.
SEMINARS IN CANCER BIOLOGY (2020)
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
Jing Xie et al.
FRONTIERS IN PHARMACOLOGY (2020)
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
Relinde I. Y. Lieverse et al.
MOLECULAR ONCOLOGY (2020)
Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases
Chad S. Hewitt et al.
BIOCHEMISTRY (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Resolving the Complexity of Ubiquitin Networks
Katarzyna Kliza et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases
Natasha Pascoe et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif
Noah Manczyk et al.
PROTEIN SCIENCE (2019)
Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15
Joan Teyra et al.
STRUCTURE (2019)
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors
Yihan Peng et al.
NATURE COMMUNICATIONS (2019)
Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site
Edmond R. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Peptides meet ubiquitin: Simple interactions regulating complex cell signaling
Gianluca Veggiani et al.
PEPTIDE SCIENCE (2019)
USP7: combining tools towards selectivity
Lorina Gjonaj et al.
CHEMICAL COMMUNICATIONS (2019)
Development of a DUB-selective fluorogenic substrate
Lorina Gjonaj et al.
CHEMICAL SCIENCE (2019)
The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency
Noah Manczyk et al.
SCIENTIFIC REPORTS (2019)
Recent advances in the development of gene delivery systems
Y. K. Sung et al.
BIOMATERIALS RESEARCH (2019)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases
Maryna Gorelik et al.
STRUCTURE (2018)
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
Arlene J. George et al.
FRONTIERS IN GENETICS (2018)
Peptides as Therapeutic Agents for Inflammatory-Related Diseases
Sara La Manna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells
Victoria J. Gennaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson's disease models
Jinlin Su et al.
CELL DEATH & DISEASE (2018)
Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10
Wei Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
A Highly Diverse and Functional Naive Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents
Isabel Leung et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
An Interaction Landscape of Ubiquitin Signaling
Xiaofei Zhang et al.
MOLECULAR CELL (2017)
A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants
Mads Gabrielsen et al.
MOLECULAR CELL (2017)
Faster, deeper, smaller-the rise of antibody-like scaffolds
Brian Owens
NATURE BIOTECHNOLOGY (2017)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha-helical ubiquitin interacting motif
Noah Manczyk et al.
PROTEIN SCIENCE (2017)
Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
Joseph S. Bednash et al.
NATURE COMMUNICATIONS (2017)
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants
Wei Zhang et al.
PLOS PATHOGENS (2017)
Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3
Arno F. Alpi et al.
BIOCHEMICAL JOURNAL (2016)
Divergence in Ubiquitin Interaction and Catalysis among the Ubiquitin-Specific Protease Family Deubiquitinating Enzymes
Adam H. Tencer et al.
BIOCHEMISTRY (2016)
E2 enzymes: more than just middle men
Mikaela D. Stewart et al.
CELL RESEARCH (2016)
System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
Wei Zhang et al.
MOLECULAR CELL (2016)
Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface
Maryna Gorelik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interplay between the virus and the ubiquitin-proteasome system: molecular mechanism of viral pathogenesis
Honglin Luo
CURRENT OPINION IN VIROLOGY (2016)
Protein engineering by highly parallel screening of computationally designed variants
Mark G. F. Sun et al.
SCIENCE ADVANCES (2016)
Phage Lambda Capsids as Tunable Display Nanoparticles
Jenny R. Chang et al.
BIOMACROMOLECULES (2014)
Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
Anupama Pal et al.
CANCER RESEARCH (2014)
Novel Ubiquitin-derived High Affinity Binding Proteins with Tumor Targeting Properties
Susan Lorey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
TRAF6 Stimulates the Tumor-Promoting Effects of TGFβ Type I Receptor Through Polyubiquitination and Activation of Presenilin 1
Shyam Kumar Gudey et al.
SCIENCE SIGNALING (2014)
Functions of SAGA in development and disease
Li Wang et al.
EPIGENOMICS (2014)
The DUSP-Ubl domain of USP4 enhances its catalytic efficiency by promoting ubiquitin exchange
Marcello Clerici et al.
NATURE COMMUNICATIONS (2014)
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
Maria Stella Ritorto et al.
NATURE COMMUNICATIONS (2014)
Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins
Nathan W. Pierce et al.
CELL (2013)
Targeting the ubiquitin-proteasome system for cancer therapy
Min Shen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Analyses of the Effects of All Ubiquitin Point Mutants on Yeast Growth Rate
Benjamin P. Roscoe et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7
Yingnan Zhang et al.
NATURE CHEMICAL BIOLOGY (2013)
Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome
Laura M. McDonell et al.
NATURE GENETICS (2013)
E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1
Reuven Wiener et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Conformational dynamics control ubiquitin-deubiquitinase interactions and influence in vivo signaling
Aaron H. Phillips et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Strategy for Modulation of Enzymes in the Ubiquitin System
Andreas Ernst et al.
SCIENCE (2013)
UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation
Hong Wu et al.
CELL CYCLE (2011)
Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases
Mariola J. Edelmann et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Impact of linker length on the activity of PROTACs
Kedra Cyrus et al.
MOLECULAR BIOSYSTEMS (2011)
Mechanism of USP7/HAUSP Activation by Its C-Terminal Ubiquitin-like Domain and Allosteric Regulation by GMP-Synthetase
Alex C. Faesen et al.
MOLECULAR CELL (2011)
TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer
Yabing Mu et al.
NATURE COMMUNICATIONS (2011)
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Jian Yuan et al.
CELL (2010)
Ubiquitin: Same Molecule, Different Degradation Pathways
Michael J. Clague et al.
CELL (2010)
Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8.STAM Complex
Ilana Berlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Diversity of Ubiquitin Recognition: Hot Spots and Varied Specificity
Jason M. Winget et al.
MOLECULAR CELL (2010)
Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by tandem UIMs of RAP80
Yusuke Sato et al.
EMBO JOURNAL (2009)
Linkage-Specific Avidity Defines the Lysine 63-Linked Polyubiquitin-Binding Preference of Rap80
Joshua J. Sims et al.
MOLECULAR CELL (2009)
Ubiquitin-binding domains - from structures to functions
Ivan Dikic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides:: a comparative study
Samir El-Andaloussi et al.
BIOCHEMICAL JOURNAL (2007)
The ubiquitin-specific protease USP28 is required for MYC stability
Nikita Popov et al.
NATURE CELL BIOLOGY (2007)
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Lauren F. Stevenson et al.
EMBO JOURNAL (2007)
Reading protein modifications with interaction domains
Bruce T. Seet et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Stewart H. Lecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Essential role of E2-25K/Hip-2 in mediating amyloid-β neurotoxicity
S Song et al.
MOLECULAR CELL (2003)